Tilray Brands gains approval for in-house cannabis testing in Portugal

Mugglehead
By Theo MarchettiOct 13, 2026, 9:37 am66 pts
Portugal's medicines regulator INFARMED has approved in-house quality testing at a medical cannabis facility in Cantanhede, according to an Oct. 13 announcement. Tilray Brands, Inc. (NASDAQ: TLRY) (TSE: TLRY) says the approval brings two testing categories in-house for a medical cannabis division that has…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Your Data, Your AI: AROYA Connects Growers’ Cultivation Data to Claude and ChatGPT 77

Study Estimates Federal Hemp THC Beverage Restrictions Could Cost Consumers Up to $146 Million Annually 71

Illinois Marijuana Businesses Face November 1 Deadline for New THC and Cannabinoid Labeling Requirements 67

Tilray Brands gains approval for in-house cannabis testing in Portugal 65

Study Finds Single Ultra-Low Dose of THC Reduces Anxiety-Like Behavior in Mice Three Weeks After Treatment 65

U.S. Legal Marijuana Sales Reach $2.52 Billion in September, Bringing 2026 Total to $21.6 Billion 59

Webinar Recording: DEA Enforcement, Cannabis Rescheduling, and Hemp Regulation 56

Minnesota Releases Detailed List of Medical Marijuana Products Dispensaries Must Stock Starting January 1 49

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.